152 related articles for article (PubMed ID: 26714600)
41. Evaluation of Tumor Hypoxia in C6 Glioma Rat Model With Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Hou W; Xue Y; Tang W; Pan H; Xu M; Li X; Bi S; Shen Y; Qian Y; Yu Y
Acad Radiol; 2019 Aug; 26(8):e224-e232. PubMed ID: 30385206
[TBL] [Abstract][Full Text] [Related]
42. Differentiating between benign and malignant sinonasal lesions using dynamic contrast-enhanced MRI and intravoxel incoherent motion.
Jiang J; Xiao Z; Tang Z; Zhong Y; Qiang J
Eur J Radiol; 2018 Jan; 98():7-13. PubMed ID: 29279173
[TBL] [Abstract][Full Text] [Related]
43. A comparison of arterial spin labeling perfusion MRI and DCE-MRI in human prostate cancer.
Cai W; Li F; Wang J; Du H; Wang X; Zhang J; Fang J; Jiang X
NMR Biomed; 2014 Jul; 27(7):817-25. PubMed ID: 24809332
[TBL] [Abstract][Full Text] [Related]
44. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of pancreatic ductal adenocarcinoma from other pancreatic solid lesions.
Liu K; Xie P; Peng W; Zhou Z
J Comput Assist Tomogr; 2014; 38(5):681-6. PubMed ID: 24943251
[TBL] [Abstract][Full Text] [Related]
45. Parotid perfusion in nasopharyngeal carcinoma patients in early-to-intermediate stage after low-dose intensity-modulated radiotherapy: evaluated by fat-saturated dynamic contrast-enhanced magnetic resonance imaging.
Cheng CC; Chiu SC; Jen YM; Chang HC; Chung HW; Liu YJ; Chiu HC; Chen CY; Huang GS; Juan CJ
Magn Reson Imaging; 2013 Oct; 31(8):1278-84. PubMed ID: 23664679
[TBL] [Abstract][Full Text] [Related]
46. The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma.
Yan DF; Zhang WB; Ke SB; Zhao F; Yan SX; Wang QD; Teng LS
BMC Cancer; 2017 Oct; 17(1):678. PubMed ID: 29020937
[TBL] [Abstract][Full Text] [Related]
47. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
[TBL] [Abstract][Full Text] [Related]
48. Early evaluation of irradiated parotid glands with intravoxel incoherent motion MR imaging: correlation with dynamic contrast-enhanced MR imaging.
Zhou N; Chu C; Dou X; Li M; Liu S; Zhu L; Liu B; Guo T; Chen W; He J; Yan J; Zhou Z; Yang X; Liu T
BMC Cancer; 2016 Nov; 16(1):865. PubMed ID: 27821130
[TBL] [Abstract][Full Text] [Related]
49. DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1α, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma patients.
Huang W; Zhang Q; Wu G; Chen PP; Li J; McCabe Gillen K; Spincemaille P; Chiang GC; Gupta A; Wang Y; Chen F
Radiother Oncol; 2021 Nov; 164():146-154. PubMed ID: 34592360
[TBL] [Abstract][Full Text] [Related]
50. [Influences of magnetic resonance imaging on the staging system of nasopharyngeal carcinoma].
Sun Y; Mao YP; Ma J; Huang Y; Tang LL; Wang Y; Liu LZ; Lu TX
Ai Zheng; 2007 Feb; 26(2):158-63. PubMed ID: 17298745
[TBL] [Abstract][Full Text] [Related]
51. Prognostic aspects of DCE-MRI in recurrent rectal cancer.
Gollub MJ; Cao K; Gultekin DH; Kuk D; Gonen M; Sohn M; Schwartz LH; Weiser MR; Temple LK; Nash GM; Guillem JG; Wang M; Garcia-Aguilar J; Goodman K; Paty PB
Eur Radiol; 2013 Dec; 23(12):3336-44. PubMed ID: 23979104
[TBL] [Abstract][Full Text] [Related]
52. Evaluating the scope of intramedullary invasion of malignant bone tumor by DCE-MRI quantitative parameters in animal study.
Zhang Y; Tan Y; Dong C; Gao S; Xu W; Chen H
J Bone Oncol; 2019 Dec; 19():100269. PubMed ID: 31799112
[TBL] [Abstract][Full Text] [Related]
53. Dynamic contrast-enhanced MRI for advanced esophageal cancer response assessment after concurrent chemoradiotherapy.
Sun NN; Liu C; Ge XL; Wang J
Diagn Interv Radiol; 2018 Jul; 24(4):195-202. PubMed ID: 30091709
[TBL] [Abstract][Full Text] [Related]
54. Contrast-enhanced dynamic and diffusion-weighted magnetic resonance imaging at 3.0 T to assess early-stage nasopharyngeal carcinoma.
Ni L; Liu Y
Oncol Lett; 2018 Apr; 15(4):5294-5300. PubMed ID: 29552169
[TBL] [Abstract][Full Text] [Related]
55. Role of perfusion parameters on DCE-MRI and ADC values on DWMRI for invasive ductal carcinoma at 3.0 Tesla.
Liu F; Wang M; Li H
World J Surg Oncol; 2018 Dec; 16(1):239. PubMed ID: 30577820
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of the reproducibility of a protocol for the pharmacokinetic study of breast tumors by dynamic magnetic resonance imaging.
Etxano J; García-Lallana Valbuena A; Antón Ibáñez I; Elizalde A; Pina L; García-Foncillas J; Boni V
Radiologia; 2015; 57(1):44-9. PubMed ID: 24525219
[TBL] [Abstract][Full Text] [Related]
57. Association between penile dynamic contrast-enhanced MRI-derived quantitative parameters and self-reported sexual function in patients with newly diagnosed prostate cancer.
Vargas HA; Donati OF; Wibmer A; Goldman DA; Mulhall JP; Sala E; Hricak H
J Sex Med; 2014 Oct; 11(10):2581-8. PubMed ID: 24754351
[TBL] [Abstract][Full Text] [Related]
58. Value of contrast-enhanced MRI in the differentiation between nasopharyngeal lymphoid hyperplasia and T1 stage nasopharyngeal carcinoma.
Wang ML; Wei XE; Yu MM; Li WB
Radiol Med; 2017 Oct; 122(10):743-751. PubMed ID: 28647899
[TBL] [Abstract][Full Text] [Related]
59. Tumor metabolism and perfusion ratio assessed by 18F-FDG PET/CT and DCE-MRI in breast cancer patients: Correlation with tumor subtype and histologic prognostic factors.
An YS; Kang DK; Jung YS; Han S; Kim TH
Eur J Radiol; 2015 Jul; 84(7):1365-70. PubMed ID: 25886700
[TBL] [Abstract][Full Text] [Related]
60. Prognostic Prediction Based on Dynamic Contrast-Enhanced MRI and Dynamic Susceptibility Contrast-Enhanced MRI Parameters from Non-Enhancing, T2-High-Signal-Intensity Lesions in Patients with Glioblastoma.
Jo SW; Choi SH; Lee EJ; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
Korean J Radiol; 2021 Aug; 22(8):1369-1378. PubMed ID: 33987994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
